Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008074

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2008074

Asia Pacific Wound Care Biologics Market, By Product Type, By Application, By End User, By Geography

PUBLISHED:
PAGES: 153 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Asia Pacific Wound Care Biologics Market is estimated to be valued at USD 398.5 Mn in 2026 and is expected to reach USD 665.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 398.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.60% 2033 Value Projection: USD 665.6 Mn

Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity. Wound care biologic dressings are increasingly used in post surgeries and severe trauma cases, as they provide a moist healing environment aiding heat, protein, and electrolyte loss for faster healing and prevent bacterial contamination. Biologic skin substitutes are healing therapies intended to facilitate innate repair mechanisms, control associated pain, and promote healing of the wound. Enzyme-based formulations including collagen play an essential role in wound healing such as hemostasis, inflammation, and remodeling, as collagen facilitates wound healing through the organization and accumulation of freshly formed fibers and granulation tissue, creating a healing environment. Growth factors are polypeptides that control the growth, differentiation, and metabolism of cells. These factors are hormone-like molecules that interact with specific cell surface receptors to control the process of tissue repair.

Market Dynamics

Rising medical tourism in Asia Pacific is encouraging an influx of foreign patients for affordable treatment. This had been facilitating hospitals, wound care clinics, and ambulatory surgical care centers to expand the range of wound care biologics products that are used post-surgical interventions for wound management. For instance, according to data published by Health Analytics Asia, a data-driven platform to bring journalists, doctors, and data scientists together to shape health reporting in Asia, in 2019, it had been reported that one million medical tourists visited Malaysia and 3.3 million medical tourists visited Thailand in 2017. India also saw a surge from 4,27,014 medical tourists in 2016 to 4,95,056 medical tourists in 2017.

Key features of the study

  • This report provides an in-depth analysis of the Asia Pacific wound care biologics market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Asia Pacific Wound Care Biologics Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Smith & Nephew Plc, Organogenesis, Inc., Integra LifeSciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amnio Technology LLC, Osiris Therapeutics, Inc., Anika Therapeutics, Inc., Zimmer Biomet, Wright Medical Group N.V., and Kerecis
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Asia Pacific Wound Care Biologics Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia Pacific wound care biologics market

Market Segmentation

  • By Product Type
    • Biologic Skin Substitutes
    • Enzyme Based Formulations
  • By Application
    • Chronic Wounds
    • Diabetic Foot Ulcers
    • Venous Leg Ulcers
    • Pressure Ulcers
    • Acute Wounds
    • Surgical Wounds
    • Burns
  • By End User
    • Hospitals
    • In-patient Settings
    • Out-patient Settings
    • Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
  • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Key Players
    • Smith & Nephew Plc
    • Organogenesis, Inc.
    • Integra LifeSciences Holdings Corporation
    • Skye Biologics
    • Alphatec Holdings, Inc.
    • Solsys Medical LLC
    • Amnio Technology LLC
    • Osiris Therapeutics, Inc.
    • Anika Therapeutics, Inc.
    • Zimmer Biomet
    • Wright Medical Group N.V.
    • Kerecis
Product Code: CMI5043

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Regulatory Scenario
  • PEST Analysis
  • Epidemiology
  • Product Launch/Approvals
  • Acquisition, Collaboration & Agreements
  • Key Developments
  • Alternative Wound Care Management Products

4. Asia Pacific Wound Care Biologics Market, By Product Type, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2033 (%)
    • Y-o-Y Growth Analysis, 2018- 2033
    • Segment Trends
  • Biologic Skin Substitutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Enzyme Based Formulations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Asia Pacific Wound Care Biologics Market, By Application, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2022 and 2033 (%)
    • Y-o-Y Growth Analysis, 2018 - 2033
    • Segment Trends
  • Chronic Wounds
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
      • Diabetic Foot Ulcers
      • Venous Leg Ulcers
      • Pressure Ulcers
  • Acute Wounds
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
      • Surgical Wounds
      • Burns

6. Asia Pacific Wound Care Biologics Market, By End User, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2022 and 2033 (%)
    • Y-o-Y Growth Analysis, 2018 - 2033
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
      • In-patient Settings
      • Out-patient Settings
  • Clinics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Home Care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Asia Pacific Wound Care Biologics Market, By Country, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • China
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
  • India
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
  • Japan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
  • Australia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
  • South Korea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
  • ASEAN
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)
  • Rest of APAC
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (USD Mn)

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Smith & Nephew Plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Organogenesis, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Integra LifeSciences Holdings Corporation
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Skye Biologics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Alphatec Holdings, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Solsys Medical LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Amnio Technology LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Osiris Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Anika Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Zimmer Biomet
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Wright Medical Group N.V.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
    • Kerecis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategy
      • Analyst Views

9. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!